In September 1999, Wanfangjian Company was established.
In December 2000, the company established its first new drug research and development laboratory. In the same month, China's first new liposome drug for the treatment of deep fungal infections was introduced from the United States and obtained a drug import license issued by the State Food and Drug Administration.
In September 2001, the company moved into the Guangzhou Mayor Building.
In May 2002, the company established its second new drug research and development laboratory.
In March 2003, the company officially decided to establish Guangzhou Langsheng Pharmaceutical and chose its location in Guangzhou Science City.
In May 2003, Langsheng Pharmaceutical was officially registered and established birth control drugs as the company's first professional development direction. In August of the same year, it obtained a pharmaceutical enterprise project license issued by the Guangdong Provincial Food and Drug Administration. certificate.
In February 2004, the company obtained clinical approval from the State Food and Drug Administration for levonorgestrel enteric-coated tablets and was allowed to conduct clinical research. The company became the first company in the world to study levonorgestrel enteric-coated tablets. Pharmaceutical manufacturer of emergency contraceptive pills.
In April 2004, the enterprise project located in Guangzhou Science City, covering an area of ??20,000 square meters, broke ground.
In October 2004, it obtained the second clinical approval document for birth control drugs issued by the State Food and Drug Administration.
In November 2004, the company built the first modern production line for steroid technology in accordance with the GMP standards of WHO and the State Food and Drug Administration.
On February 28, 2005, the new factory building and office laboratory building were completed, and the company officially moved from the Guangzhou Mayor Building.
In April 2005, we signed a cooperation agreement with the Chinese University of Hong Kong on a new class I anti-tumor drug.
In November 2005, the company’s first pilot workshop for freeze-dried injection preparations was completed and put into use.
In October 2007, it reached an international strategic cooperation agreement with the American HM Company.
In January 2008, it obtained the national new drug certificate and production approval for levonorgestrel enteric-coated tablets issued by the State Food and Drug Administration.
In June 2008, it officially passed the GMP inspection and certification of the Food and Drug Administration, and in July of the same year, it obtained the GMP certificate for the steroid hormone solid and oral preparation workshop.
In August 2008, the company submitted more than ten new birth control drug varieties to the State Food and Drug Administration. So far, the company has obtained clinical approval for four new birth control drugs. One of them is levonorgestrel enteric-coated tablets.
In September 2008, the company launched the first phase of Danmei advertising creativity and graphics
In October 2008, the official website of Langsheng Pharmaceutical was launched
January 2009 The monthly 400 customer service hotline was opened
In April 2009, the company participated in the 61st National Pharmaceutical Fair held in Zhengzhou, Henan
In July 2009, Danmei’s brand image was fully upgraded. Meili cartoon image was grandly launched
In July 2009, the company's product website - Meili.com was completed and successfully launched
In July 2009, Danmei's "Meili" magazine was launched
In August 2009, the company participated in the 5th Reproductive Health Expo
In September 2009, Danmei’s first advertising film and television creative was completed and the film and television advertising shooting and production was carried out
Invention patent issued on September 16, 2009: "Dosage Form for Delaying the Dissolution of Solid Oral Contraceptives or Pregnancy Termination Drugs and Their Application" was authorized by the State Intellectual Property Office, patent number: ZL02148956.4
In November 2009, the company participated in the 62nd National Drug Fair held in Chengdu, Sichuan
In November 2009, mobile phone media advertising was officially launched
In December 2009, Danmei 0.75mg was launched on the market
In December 2009, the company won the title of "Key Overseas Chinese Entrepreneurship Team of the State Council Overseas Chinese Affairs Office" issued by the Overseas Chinese Affairs Office of the State Council
In December 2009, General Manager Lu Zhijun won the title of "Key Overseas Chinese Entrepreneurship Team" issued by the Overseas Chinese Affairs Office of the State Council. The Second Outstanding Entrepreneurship Award for One Hundred Overseas Chinese Professionals"
From January to March 2010, the company's TV commercials were broadcast on Jiangsu Satellite TV and Hunan Satellite TV during prime time